Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ocular Therapeutix (OCUL) Receivables - Net (2016 - 2025)

Ocular Therapeutix has reported Receivables - Net over the past 13 years, most recently at $30.6 million for Q4 2025.

  • Quarterly results put Receivables - Net at $30.6 million for Q4 2025, down 5.37% from a year ago — trailing twelve months through Dec 2025 was $30.6 million (down 5.37% YoY), and the annual figure for FY2025 was $30.6 million, down 5.37%.
  • Receivables - Net for Q4 2025 was $30.6 million at Ocular Therapeutix, roughly flat from $30.8 million in the prior quarter.
  • Over the last five years, Receivables - Net for OCUL hit a ceiling of $32.4 million in Q4 2024 and a floor of $13.6 million in Q1 2021.
  • Median Receivables - Net over the past 5 years was $24.4 million (2023), compared with a mean of $24.6 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 551.84% in 2021 and later dropped 8.98% in 2023.
  • Ocular Therapeutix's Receivables - Net stood at $21.1 million in 2021, then increased by 0.9% to $21.3 million in 2022, then increased by 22.76% to $26.2 million in 2023, then increased by 23.72% to $32.4 million in 2024, then dropped by 5.37% to $30.6 million in 2025.
  • The last three reported values for Receivables - Net were $30.6 million (Q4 2025), $30.8 million (Q3 2025), and $30.4 million (Q2 2025) per Business Quant data.